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Abstract
This review evaluated the level of informatics in glucometers through an assessment
of the quantity and types of information and advice provided to users. Manufacturer
websites were investigated and the characteristics of glucometers were examined. 100
glucometers from 27 manufacturers were analysed. Many glucometers contained
simple informatics features and 5 also contained on-device graphing features for users
to monitor trends. Some manufacturers have extended informatics via external
software. A small number of glucometers provided knowledge for the user by, for
example, simple embedded decision support protocols. However, it is suggested that
glucometers could better serve as primary care devices through the incorporation of
more decision support directly on the device.
1 Introduction
The change in emphasis from acute to primary care is producing a requirement for a
new generation of medical monitoring devices. As well as the technical challenges
that will need to be overcome, informatics challenges must be met, if device users are
to obtain full services from such devices. In particular, problems with future point-of-
care devices for medical use may result from the inaccuracy, poor transmission,
garbled reception or misinterpretation of the information they are designed to provide
[1]. It is useful therefore, to assess the state-of-the-art in informatics for current
medical monitoring devices, of which the most sophisticated and widely used
example is the blood glucometer. This paper represents such an assessment, along
with a comparison of the state-of-the-art with medical informatics models.
1.1 Background on Diabetes
Diabetes Mellitus is a chronic condition characterised by elevated blood glucose due
to absolute or relative deficiency in insulin. In 2000, it was estimated that there were
171 million people in the world with diabetes [2]. The classic symptoms of diabetes
include “increased urinary frequency (polyuria), excessive thirst (polydipsia),
excessive hunger (polyphagia) and unexplained weight loss” [3] and these aid in its
diagnosis along with a blood test. The World Health Organization (WHO) describes
two main types [3].
Type 1 Diabetes (Insulin-Dependent Diabetes Mellitus) - is commonly found in
children and adolescents in whom the pancreas is unable to produce sufficient insulin
to metabolize glucose in the blood thus resulting in hyperglycaemia. Type 2 Diabetes
(Non-Insulin-Dependent Diabetes Mellitus) - usually occurs in adults and is related to
obesity and unhealthy diets. There is a third type which only affects pregnant women
- Gestational Diabetes, but this is generally a temporary condition normally resolved 6
weeks after delivery. However the risk of developing Type 2 Diabetes in the future is
increased.
1.2 Monitoring Diabetes
Patients with diabetes need to monitor their blood glucose regularly as there are risks
associated with high blood glucose in the body including: eye damage, leading to
blindness; kidney damage, leading to renal failure; nerve damage, leading to
impotence and foot ulcers which may result in amputation (diabetes is the leading
cause of non traumatic amputation); ketoacidosis, a high concentration of ketones in
the body occurring when the body is unable to metabolize glucose for the cells, thus
finding an alternative by using fat and proteins instead; heart disease; stroke; coma -
in extreme cases [4].
Blood glucose monitoring for patients can be done through regular visits to their
health professional, however patients can also monitor their own blood glucose
regularly with a glucometer or glucose meter.
1.3 Glucometers
Glucometers are designed for monitoring rather than for diagnosing diabetes. Some
glucometers require coding, which refers to calibrating the meter to the batch of test
strips being used as there is variation between batches of strips. If the glucometer is
not calibrated, it will give an incorrect result [5].
The blood sample for the test is generally taken from the fingertip as this provides the
most accurate result but it also causes the patient the most pain because the fingertips
contain many nerve endings. Therefore some glucometers allow the testing of blood
samples from other sites and this is known as alternative site testing (AST). The sites
include “upper-arms, thighs, base of the thumb, stomach areas and forearms” [6 - 8].
A lancet is needed to obtain the blood sample and it has different settings to determine
the depth to which the skin will be pierced, which helps in determining the size of
sample obtained. Modern glucometers are able to analyze relatively small amounts of
blood (minimum of 0.3µL).
The test strips for glucometers vary and the latest ones available are designed to allow
easier blood application. Some have a confirmation window that will provide
assurance to the patient that a sufficient amount of blood has been provided [9].
Glucometers provide the blood glucose results in specified units: either mg/dL (which
is the standard for USA) or mmol/L (which is the standard in UK, Canada and some
European countries). Some glucometers have the capacity to store the results and
some also have averaging features to aid users in gaining an overview of their blood
glucose levels over periods of time.
1.4 Aim
The aim of this review was to ascertain the state-of-the-art in informatics for
glucometers. The level of informatics available on the device was analysed and the
quantity and types of information provided to users were investigated. The review
describes the methodology used, gives the results obtained from that methodology,
discusses the findings and compares them against the state-of-the-art in informatics.
2 Methodology
A key word search was carried out to identify different types of commercially
available glucometers. An on-line resource, for example [10], and the British National
Formulary (BNF) were of particular assistance.
Glucometer manufacturers’ websites were investigated to obtain the details of the
glucometers they supplied. In total, information on 100 glucometers, available
between the years 1998 and 2008, was obtained. This represented 27 manufacturers.
The list of glucometers assembled for this review was not exhaustive; however it
included popular brands available, for example, Abbott, Bayer, LifeScan and Roche
Diagnostics.
The operating manuals of 72% of glucometers were available online or after request
from manufacturers. There were no manuals for 28% of devices by 14
manufacturers/distributors thus resulting in incomplete information. However, a short
description was normally provided by the manufacturer for those glucometers that did
not have online manuals. The manuals contained detailed instructions on how to
operate the glucometer as well as its features and specification.
The manuals were analysed to obtain glucometer specifications and operating details.
A categorization scheme was drawn up to investigate whether glucometers possessed
particular informatics features. Where glucometers were supplemented with “off-
device” data management software, the capabilities of the software were analysed.
The results obtained are presented below in five groups: information before testing,
testing, on-device data manipulation after testing, off-device data-management
software capabilities and “advice” given by the glucometer.
3 Results
3.1 Information before testing
67% of devices reviewed required coding and 27% did not. Information about coding
could not be obtained for 6% of devices.
19% of devices had the option of setting reminders for the patient to test, therefore
showing many manufacturers have not considered this as an essential feature to
incorporate.
62% of devices displayed an error message indicating that the glucometer was not
operating in the right temperature range. In addition, 37% of devices also displayed a
thermometer symbol on their screen to indicate that it was not operating in the right
temperature range.
3.2 Testing
The time taken to generate results on devices was compared and the range was
between 3-50 seconds. Some devices provided a time range for the time taken to
obtain the result and for the purpose of data analysis this was adjusted to the
maximum time given. The shortest time taken to obtain test results was 3 seconds and
that was seen in 1 device – “Evolution” (Infopia). The majority of the devices (3 0%)
generated their result in 5 seconds, followed by 20% of devices generating their result
in 10 seconds and 15% of devices generating results in 7 seconds (see Figure 1). The
maximum time recorded was 50 seconds on “Prestige IQ” (Home diagnostics).













Figure 1 - Duration of the test.
3.3 On-device data manipulation after testing
20% of devices allowed results to be flagged or marked with a symbol in order to
associate a particular event to the result.
5% allowed users to add a comment to annotate the result. The glucometers provided
predefined comments for users to select from. Table I shows examples of the
comments available. Normally, the comments were found in a single list. However,
the “OneTouch UltraSmart” (Life Scan) glucometer divided them into four categories
– Food, Health, Exercise and Medication.
Table 1 – A summary of comments provided on five glucometers to annotate the results.
Glucometer Available Comments
Accu-Chek Complete Before Meal, After Meal, Fasting, Snack, Feel
(Roche Diagnostics) Hypo., Before Exercise, After Exercise, Illness,
Invalid Test, Other’s Result, User Defined,
Stress, L1 Control, L2 Control, Oral Medication
OneTouch Profile Fasting, pre breakfast, after breakfast, pre noon
(LifeScan) meal, after noon meal, pre dinner, after dinner,
different food, bedtime, during night, pre
exercise, after exercise, illness, hypoglycemia,
other
OneTouch UltraLink No comment, Stress, Not enough food, Illness,
(LifeScan); Too much food, Feel hypo, Mild exercise,
OneTouch Ultra2 Menses (period), Hard exercise, Vacation,
(LifeScan) Medication, Other
OneTouch UltraSmart Food Comments – BefBrkft, Aft Brkft, Bef
(LifeScan) Lunch, Aft Lunch, Bef Dinner, Aft Dinner and
Night
Health Comments – Stress, Feel Hypo, Illness,
Menses, Vacation, Other
Exercise Comments – Before, During, After
Medication - None
81% of devices calculated an average of the results recorded. Devices varied in the
number of days over which an average could be calculated, and in how many
variations of averages were permitted. The maximum number of variations of the
average was 6 types i.e. 7, 14, 21, 28, 60 and 90-day averages. Figure 2 plots the
amount of glucometers against the number of types of average which they were able
to display.












Figure 2 - Types of averages calculated on glucometers.
The majority of devices (21%) calculated three types of averages, with 15% that
calculated 7, 14 and 30-day averages, 2% that calculated 7, 14 and 28-day averages
and 3% that calculated 14, 30, 90-day averages. One device, “Eclipse” (Infopia)
allowed the patient to set 3 unique averages. 20% calculated six types of averages and
19% calculate 1 type of average. Glucometers calculating six types of averages were
limited to four manufacturers: CardioCom, Diabetic Supply of Suncoast Inc.,
Diagnostic Devices Inc. and TaiDoc.
79% of devices allowed results to be downloaded to a computer, thus showing that a
majority of manufacturers have considered this as a feature to include. 11% did not
allow results to be downloaded. Manufacturer’s information for downloading could
not be obtained for 10% of glucometers.
3.4 Off-Device data-management software
51% of glucometers were found to be available with data management software,
which extended data analysis “off device”.
Of these software packages, 90% required data to be transferred via a USB cable;
10% used infra-red connection.
80% highlighted outliers in the blood glucose concentration either within a “logbook”
or in graphs generated.
90% allowed the generation of reports, the numbers of types of reports ranging from 5
to 12. 40% allowed reports to be emailed, however printing or faxing of results were
offered as an alternative.
60% allowed the importing of extra data in addition to the data downloaded from
glucometers. 30% did not have import facilities. Manufacturer’s information could
not be obtained for the remaining 10%. 70% allowed exporting of data to another
application whereas 20% did not have export facilities. Manufacturer’s information
could not be obtained for the remaining 10%.
All the software packages reviewed the calculated averages. 70% had further
statistical analysis capabilities such as standard deviation, minimum and maximum.
3.5 On-device and off-device “advice”
77% of devices displayed a comment for example “hi” or “lo” whenever the blood
glucose result was not within the specified measuring range of the device. All
manuals included definitions of these comments. The measuring range of 53% of the
glucometers was between 20 and 600 mg/dL (or 1.1 - 33.3 mmol/L). For 23%,
manufacturer’s information could not be obtained. Within these 77 devices, 73%
specified in the manual that users needed to repeat their test to confirm the results,
whenever these warning comments were displayed.
Certain glucometers also provided warnings for actual, measured values of blood
glucose that were particularly high or low. When a user’s blood glucose was lower
than a specific range, “OneTouch Profile” (Life Scan) and “OneTouch UltraSmart”
(LifeScan) glucometers displayed a message: “Do you need a snack”?
“Danger” or “Call Dr” was displayed on “OneTouch Profile” (LifeScan) when a
user’s blood glucose was higher than the specified range. The other glucometers
displayed a message related to checking ketones in the blood.
“Accu-Chek Complete” (Roche Diagnostics) displayed a message while the user was
carrying out a test, known as the tip of the day, which sometimes provided a reminder
or supplied information to the user about managing their diabetes.
21% of glucometers displayed messages providing advice on further action to take
based on their blood glucose result. For example, a message to check for ketones was
displayed. 52% did not provide further comments. Manufacturer’s information could
not be obtained for the remaining 27%.
“GlucoTel” (BodyTel Scientific Inc), (not yet commercially available) was specified
to incorporate human interaction in terms of the provision of advice. Once results are
transmitted and stored in the user’s electronic patient health record held on an external
database, health professionals could set the option of being alerted (via email, text
message or fax) should the user’s blood glucose result be extreme. They could then
provide the most appropriate advice to the user.
74% of glucometers were found to provide information explaining the messages that
were displayed on the glucometers. These included error messages. This information
was always placed in the manual. Manufacturer’s information could not be obtained
for the remaining 26%. 25% of glucometers surveyed had manuals that provided
multiple reasons for individual error messages, leaving some interpretation of the
message to the user. For error messages, the glucometers provided advice to the user
regarding the actions to take and in some cases users were advised to redo their test.
Error messages shown on the glucometers included issues relating to the testing
process. For example, faulty test strips, the size of the blood sample provided and the
temperature at which the test was carried out. Other error messages were related to
general problems with the glucometer which would make it unusable. Certain general
messages were provided in a pictorial form e.g. a battery symbol represented low
battery on the glucometer and a thermometer symbol indicated that the environmental
temperature for the glucometer was not in the right range.
4 Discussion
4.1 Information provided to users
Coding or calibration of a meter prior to testing is an extra step in blood glucose
testing and glucometers that are automatically coded reduce the error that may occur
in blood glucose results. 67% of the glucometers reviewed required a coding step.
Newer glucometer models have been developed with automatic coding features.
However neither set-up provided the user with an estimate of the calibration error.
As testing of glucometers indicates that glucometer inaccuracy is so high that they
cannot yet be used as a diagnostic test, this lack of error estimation is a serious
limitation on their informatics capabilities [11].
“Prodigy Eject” (Diagnostic Devices Inc) and “Assure Pro” (ARKRAY) reminded
users to carry out a control test which enabled patients to check that the glucometer
and strips were functioning correctly. This was a necessary step that needed to be
carried out occasionally to ensure that the results obtained from the glucometer were
accurate and the patient was not misinformed, which may lead to incorrect medication
being administered leading to side effects. Control tests were also suggested from the
manual when unexpected results were obtained from the glucometer.
The proportion of glucometers reviewed providing an alarm function was 19%. This
is particularly important as patient non-compliance with monitoring regimes is an
important barrier in the move from acute to primary care. In particular, users with
busy or unpredictable lifestyles, reduced memory function or those yet to establish a
monitoring routine would benefit from improved alarm functions.
Many of the reviewed glucometers incorporated a feature such that the measurement
process started automatically once a sufficient blood sample had been provided,
otherwise an error message was displayed by the glucometer.
A general trend was seen in the provision of advice to users, through the manual, of
possible post-test actions to take. 73% of glucometers instructed users to redo their
test when unexpected results were obtained. Retests were also suggested whenever
there were no factors that could be affiliated to the result obtained by user action, (see
below) (for example, the glucometer may have produced a low result, but the user had
recently had a meal). 17% of glucometers displayed a message regarding checking for
ketones. 1 glucometer “Precision Xtra” (Abbott) provided the facility to test for
ketones, allowing the user ability to immediately act on the advice.
4.2 User interaction with the results
20% of glucometers allowed results to be flagged on the device. The intention of the
flags was to highlight particular results so that when data was reviewed, users would
be able to discuss with their health professional, possible contributory factors, such as
food intake or exercise. However, the flag systems generally consisted of one letter
symbols and so could not provide detailed descriptions of factors. 6 glucometers had
added to the utility of flags by allowing their association with meals i.e. a result could
be flagged as occurring before or after a meal. For these glucometers, flagged results
were also not included in the calculation of averages of results. This was a way of
excluding outliers and the bias they may have introduced into users’ averages.
However, this assumes that the correct course of action would be to exclude these
flagged events when calculating a users’ average data.
Averaging of results was a simple and quick way of data manipulation, possessed by
81% of glucometers. This was the most advanced form of data manipulation seen on
most glucometers, although “OneTouch UltraSmart” (LifeScan), “WaveSense
Keynote” (Agamatrix), “WaveSense Keynote Pro” (Agamatrix), “Presto”
(Agamatrix) and “Accu-Chek Complete” (Roche Diagnostics) provided on-device
functionality to visualise mini graphs to observe trends in the results.
Predefined comments by manufacturers could be added to results to annotate them.
Notably, “Accu-Chek Complete” (Roche Diagnostics) provided software that allowed
comments to be modified. Incorporation of this approach into glucometers in general
would allow both users and health professionals to monitor and assess how the user’s
lifestyle was influencing their blood glucose and the advice that could be given to the
user on how to improve their health.
In order to improve functionality, 74% of manufacturers have developed off-device
software to manipulate results obtained from the glucometer. The off-device software
possessed certain common features across manufacturers, such as graphing
functionality to visualise trends and an electronic “logbook”.
All glucometers reviewed had a memory capacity. This functionality reduced the need
for users to otherwise manually log their blood-glucose data.
4.3 Glucometers and Informatics
Several informatics models exist which could be applied to glucometers. For example,
Georgiou (2002) [12], described a health informatics model comprising data,
information and knowledge where data was at the lowest level of the hierarchy and
has limited meaning on its own. Information provided context for managing data,
while knowledge provided guidance for the cause of action to take based on insight
and experience. In terms of conformity with such a health informatics model, all
glucometers evaluated displayed data. To provide information about the result, 81%
of glucometers incorporated an average function that allowed possible trends in the
data to be identified, but this was not automatically displayed. Cases where
information was provided automatically were when extreme results were displayed
(e.g. Hi or Lo); and when tests were carried out in extreme conditions (i.e. a
temperature symbol was displayed).
Some glucometers also possessed an aspect of knowledge although this was limited to
comments when an extreme result was obtained. To further improve the quality of
knowledge provided, glucometers would need to be embedded with decision support
which would incorporate results with known facts about diabetes thus aiding users in
managing their health. For example, glucometers could include a rule-based decision
framework as described by Manjanatha et al. (2007) [13]. Manjanatha noted that
current medical devices did not integrate user care information with device-generated
data, therefore advice could be provided by the device. Though the authors came to
these conclusions for devices offering continuous monitoring, which provided
information based on changing conditions of users, the information in this paper
indicates that this conclusion could be extended to stand-alone devices such as
glucometers.
5 Conclusion
The paper has described the results from an evaluation of commercial glucometers. It
has highlighted the main informatics features available. Many glucometers provide
information through their manuals. However, limited data processing and real-time
decision support, was found. It is suggested that glucometers could better serve as
primary care devices by incorporating more decision support directly on the device.
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